Epistemic Injustice as the Constitutive Context
For patients: read the epistemic-injustice and nof1-paradigm sections to recognize dismissal as a documented phenomenon and to see how your own experimentation can contribute to knowledge production.
For caregivers: skim the patient-initiated-biobanks and patient-reported-outcomes sections to understand the data resources patients built.
For clinicians: read the patient-reported-outcomes and epistemic-authority sections to weigh why patient-reported measures and testimony matter for diagnostic and research validity.
For researchers: read the epistemic-injustice framework, then the citizen-science and online-communities sections, and close with the evidence-quality and knowledge-ceiling limitations.
The infrastructure this chapter describes did not develop in a neutral environment. It developed in response to systematic epistemic exclusion — a context in which patients’ testimony about their own bodies was routinely dismissed, and their capacity to contribute to knowledge production was denied. Understanding this context is essential to understanding why ME/CFS has produced one of the most sophisticated patient-led research movements in medicine: epistemic exclusion forced the community to build its own knowledge-production institutions.
The philosopher Miranda Fricker’s concept of epistemic injustice — injustice done to someone in their capacity as a knower — distinguishes two forms (Fricker 2007):
Testimonial injustice: A speaker’s testimony is given less credibility than it deserves because of prejudice about their identity. Applied to ME/CFS: a patient reports post-exertional malaise, and the clinician attributes it to deconditioning, health anxiety, or exaggeration — in each case, discounting the testimony because of prejudice about the speaker (as a “difficult patient,” as psychosomatically ill, as unreliable about their own body).
Hermeneutical injustice: A gap in collective interpretive resources places someone at a disadvantage in making sense of their experience. Applied to ME/CFS: before the community developed the concept of post-exertional malaise (PEM), patients experienced a predictable, stereotyped collapse after activity but had no shared language to name or explain it. The experience was rendered invisible by the absence of a concept.
Blease, Carel, and Geraghty provided the first formal application of Fricker’s framework to ME/CFS, arguing that both forms of epistemic injustice are pervasive in clinical encounters with ME/CFS patients and that the consequences extend beyond the clinical encounter into research, policy, and social identity (Blease, Carel, and Geraghty 2017). A subsequent study applied the framework to Long COVID, documenting that patients faced testimonial injustice when their reports of persistent symptoms were dismissed as anxiety, and hermeneutical injustice when they lacked terminology to describe novel symptom clusters — and that it was patients who created and propagated the term “long COVID,” filling the hermeneutical gap that medical institutions had left open (Roth and Gadebusch-Bondio 2022).
The Byrne 2021 analysis extends Fricker’s framework by examining the tension between protecting patients from epistemic injustice and maintaining the legitimate epistemic authority of clinical expertise — arguing that untempered epistemic deference to patients can also produce harm, and that the goal is epistemic balance, not epistemic reversal (Byrne 2020). Ireson and colleagues documented similar dynamics in Long COVID citizen science, finding that patients experiencing hermeneutical injustice turned to online communities and citizen science projects precisely because formal healthcare had no language for their experience (Ireson et al. 2022).
(Certainty: 0.85 for Blease 2017 — top bioethics journal, first formal application; 0.72 for Roth 2022 — top-tier medical sociology, Long COVID/ME/CFS comparison; 0.65 for Byrne 2021 — mid-tier, conceptual analysis; 0.60 for Ireson 2022 — citizen science qualitative study. Severity applicability: testimonial injustice affects all severity levels — a bedbound patient who cannot attend clinic may face the most severe form (their testimony never reaches a clinician at all). Hermeneutical injustice disproportionately affected early patients who lacked shared terminology; the subsequent development of patient-created concepts like PEM, “post-exertional malaise,” “crash,” and “energy envelope” represents a community-level response to hermeneutical injustice.)
Consequence: Epistemic injustice is not a “communication problem” — it is a structural condition that determines whether patients’ experiences enter the knowledge system at all. When testimonial injustice blocks patient reports from reaching the clinical and research record, the knowledge base is systematically distorted. When hermeneutical injustice leaves patients without concepts to describe their experience, the knowledge base has literal gaps — things that exist but cannot be named, and therefore cannot be studied. The ME/CFS patient community’s response to both forms of epistemic injustice — building their own knowledge infrastructure — is the subject of the rest of this chapter.
The ME/CFS community’s epistemic exclusion has a specific history. The 2011 PACE trial — the largest ME/CFS treatment trial ever conducted, published in The Lancet — was accompanied by a 2013 follow-up analysis reporting 22% recovery rates for cognitive behavioral therapy and graded exercise therapy. This was ultimately corrected not by institutional quality control but by patient-led Freedom of Information Act requests that forced data release, followed by independent re-analysis that found recovery rates of approximately 3–7% under the original protocol definitions (Wilshire et al. 2018) (Geraghty, Hann, and Kurtev 2019). The episode is documented in detail in History of ME/CFS. For the purposes of this chapter, the PACE trial is significant not as a methodological failure but as an epistemic event: it demonstrated that patient organizations and independent analysts — not peer review, not journal correction, not institutional oversight — were the mechanism by which a flawed, high-impact finding was challenged and ultimately reversed. This event reshaped the community’s relationship to formal knowledge production. Patients learned that their own reading of the evidence — that graded exercise therapy was making them worse, not better — was more accurate than a Lancet publication. The epistemic consequences of that lesson continue to structure the patient-led research movement.
Blease and Geraghty examined the persistent media characterization of ME/CFS patient organizations as “militant” — a term routinely used in press coverage of patient advocacy, particularly around the PACE trial. Their historical-comparative analysis found that the “militant” label functions as a form of epistemic delegitimization: it frames patient advocacy as political rather than epistemic, emotional rather than rational, and thereby renders patient-generated knowledge inadmissible in scientific discourse. The analysis drew explicit parallels with AIDS activism — a movement that was also initially characterized as “militant” but that subsequently became recognized as a legitimate participant in research design and priority-setting. The authors found “no compelling evidence that the vast majority of patients with ME/CFS, or the POs representing them, have adopted any such militant political policies” — and argued that the label’s persistence despite lack of evidence is itself a symptom of epistemic injustice (Blease and Geraghty 2018).
(Certainty: 0.75 — mid-tier bioethics journal; historical-comparative method; qualitative evidence assessment. Severity applicability: N/A — this is a meta-scientific claim about the framing of patient organizations.)
Consequence: When patient advocacy is framed as “militant” activism, the knowledge claims patients advance are categorically excluded from scientific consideration — not because they are false, but because they are attributed to a political motive rather than an epistemic one. This framing has direct consequences: it shapes media coverage, influences funding decisions, and justifies institutional dismissals of patient-generated evidence. The AIDS movement’s trajectory — from “militant” outsiders to research partners — demonstrates that this framing is not immutable, but changing it requires explicit challenge, which Blease and Geraghty provide.